Literature DB >> 33360005

Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V.

Michael P Whyte1, James Aronson2, William H McAlister3, Robert S Weinstein4, Deborah Wenkert5, Karen L Clements6, Gary S Gottesman7, Katherine L Madson8, Marina Stolina9, Vinieth N Bijanki10, Horacio Plotkin11, Margaret Huskey12, Shenghui Duan13, Steven Mumm14.   

Abstract

In 2003, we briefly reported the remarkable osteopathy of a 12-year-old boy who at age two months began fracturing his limbs with subsequent hyperplastic callus formation and expansion and fusion of appendicular bones. By age ten years he had coalesced his lumbosacral spine, pelvis, femurs, and leg and foot bones as a single structure. Computed tomography of expanded bone revealed a thin cortical shell, diminished irregular trabeculae, and cystic areas. Histopathology featured foci of woven bone, densely packed osteocytes, cartilage, fibrovascular tissue, and massive fat deposition in the marrow space lacking hematogenous precursor cells. Bone turnover markers indicated accelerated remodeling and the few radiographically assessable appendicular bones improved during brief adherence to alendronate therapy. Following puberty, serum multiplex biomarker profiling confirmed accelerated bone turnover. At age 23 years, macrospecimens from leg amputation revealed ossification along capsular tissue together with hyaline cartilage degeneration. Concurrently, the life-long course of this same disorder was delineated in an unrelated woman until her death at age 51 years. Both patients demonstrated the radiographic hallmarks and harbored the heterozygous point mutation (c.-14C>T) in the 5'-UTR of IFITM5 associated with osteogenesis imperfecta type V (OI-V). Herein, we detail the clinical, radiological, histopathological, biochemical, and molecular findings and discuss the etiology and pathogenesis of this extraordinary osteopathy that we call coalescing expansile skeletal disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipogenesis; Bone-restricted ifitm-like protein; Ectopic calcification; Heterotopic ossification; Hyperostosis; Hyperplastic callus; Interferon; Interferon-induced transmembrane protein 5; Osteoblast; Osteocyte; Osteogenesis; Osteosarcoma; Periosteum; Sarcopenia; Serum multiplex biomarker profiling; Skeletal dysplasia

Mesh:

Substances:

Year:  2020        PMID: 33360005     DOI: 10.1016/j.bone.2020.115835

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  3 in total

1.  Specific Characteristic of Hyperplastic Callus in a Larger Cohort of Osteogenesis Imperfecta Type V.

Authors:  Wen-Bin Zheng; Jing Hu; Jia Zhang; Zheng Yang; Ou Wang; Yan Jiang; Wei-Bo Xia; Xiao-Ping Xing; Wei Yu; Mei Li
Journal:  Calcif Tissue Int       Date:  2022-01-06       Impact factor: 4.333

2.  The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts.

Authors:  Vincent Maranda; Marie-Hélène Gaumond; Pierre Moffatt
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

3.  A Novel IFITM5 Variant Associated with Phenotype of Osteoporosis with Calvarial Doughnut Lesions: A Case Report.

Authors:  R E Mäkitie; M Pekkinen; S Ikegawa; O Mäkitie; N Morisada; D Kobayashi; Y Yonezawa; G Nishimura
Journal:  Calcif Tissue Int       Date:  2021-06-22       Impact factor: 4.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.